Logo image of LICN

LICHEN CHINA LTD- A (LICN) Stock Fundamental Analysis

NASDAQ:LICN - Nasdaq - KYG5479G1082 - Common Stock - Currency: USD

0.0692  0 (-2.54%)

Fundamental Rating

5

Overall LICN gets a fundamental rating of 5 out of 10. We evaluated LICN against 82 industry peers in the Professional Services industry. LICN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. LICN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

LICN had positive earnings in the past year.
In the past year LICN had a positive cash flow from operations.
LICN Yearly Net Income VS EBIT VS OCF VS FCFLICN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

LICN has a better Return On Assets (10.67%) than 82.28% of its industry peers.
The Return On Equity of LICN (11.10%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 11.52%, LICN is doing good in the industry, outperforming 70.89% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LICN is above the industry average of 13.72%.
The 3 year average ROIC (18.36%) for LICN is well above the current ROIC(11.52%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 10.67%
ROE 11.1%
ROIC 11.52%
ROA(3y)16.41%
ROA(5y)N/A
ROE(3y)18.52%
ROE(5y)N/A
ROIC(3y)18.36%
ROIC(5y)N/A
LICN Yearly ROA, ROE, ROICLICN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 5 10 15 20

1.3 Margins

The Profit Margin of LICN (18.48%) is better than 88.61% of its industry peers.
LICN's Profit Margin has been stable in the last couple of years.
LICN has a better Operating Margin (26.49%) than 91.14% of its industry peers.
LICN's Operating Margin has improved in the last couple of years.
LICN has a Gross Margin of 60.71%. This is in the better half of the industry: LICN outperforms 70.89% of its industry peers.
In the last couple of years the Gross Margin of LICN has remained more or less at the same level.
Industry RankSector Rank
OM 26.49%
PM (TTM) 18.48%
GM 60.71%
OM growth 3Y2.47%
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
LICN Yearly Profit, Operating, Gross MarginsLICN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LICN is creating value.
LICN has more shares outstanding than it did 1 year ago.
There is no outstanding debt for LICN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LICN Yearly Shares OutstandingLICN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
LICN Yearly Total Debt VS Total AssetsLICN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 4.33 indicates that LICN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.33, LICN is in the better half of the industry, outperforming 78.48% of the companies in the same industry.
LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.33
ROIC/WACC1.52
WACC7.56%
LICN Yearly LT Debt VS Equity VS FCFLICN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

LICN has a Current Ratio of 17.55. This indicates that LICN is financially healthy and has no problem in meeting its short term obligations.
LICN has a Current ratio of 17.55. This is amongst the best in the industry. LICN outperforms 100.00% of its industry peers.
LICN has a Quick Ratio of 17.53. This indicates that LICN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LICN (17.53) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 17.55
Quick Ratio 17.53
LICN Yearly Current Assets VS Current LiabilitesLICN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

LICN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.78%.
The Earnings Per Share has been growing by 9.77% on average over the past years. This is quite good.
Looking at the last year, LICN shows a very negative growth in Revenue. The Revenue has decreased by -15.69% in the last year.
Measured over the past years, LICN shows a quite strong growth in Revenue. The Revenue has been growing by 9.04% on average per year.
EPS 1Y (TTM)-27.78%
EPS 3Y9.77%
EPS 5YN/A
EPS Q2Q%-51.28%
Revenue 1Y (TTM)-15.69%
Revenue growth 3Y9.04%
Revenue growth 5YN/A
Sales Q2Q%13.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LICN Yearly Revenue VS EstimatesLICN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M
LICN Yearly EPS VS EstimatesLICN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

LICN is valuated cheaply with a Price/Earnings ratio of 0.24.
98.73% of the companies in the same industry are more expensive than LICN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 30.42. LICN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.24
Fwd PE N/A
LICN Price Earnings VS Forward Price EarningsLICN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.93
LICN Per share dataLICN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

LICN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LICN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LICHEN CHINA LTD- A

NASDAQ:LICN (2/20/2025, 2:38:08 PM)

0.0692

0 (-2.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.58%
Inst Owner ChangeN/A
Ins Owners4.6%
Ins Owner ChangeN/A
Market Cap6.84M
AnalystsN/A
Price TargetN/A
Short Float %0.97%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.24
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF 1.57
P/B 0.1
P/tB 0.11
EV/EBITDA -1.93
EPS(TTM)0.29
EY419.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.04
OCFY63.82%
SpS0.42
BVpS0.71
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.67%
ROE 11.1%
ROCE 15.92%
ROIC 11.52%
ROICexc 22.58%
ROICexgc 25.95%
OM 26.49%
PM (TTM) 18.48%
GM 60.71%
FCFM N/A
ROA(3y)16.41%
ROA(5y)N/A
ROE(3y)18.52%
ROE(5y)N/A
ROIC(3y)18.36%
ROIC(5y)N/A
ROICexc(3y)35.45%
ROICexc(5y)N/A
ROICexgc(3y)44.68%
ROICexgc(5y)N/A
ROCE(3y)25.47%
ROCE(5y)N/A
ROICexcg growth 3Y-13.48%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.86%
ROICexc growth 5YN/A
OM growth 3Y2.47%
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 150.24%
Cap/Sales 10.58%
Interest Coverage 250
Cash Conversion 31.06%
Profit Quality N/A
Current Ratio 17.55
Quick Ratio 17.53
Altman-Z 4.33
F-Score5
WACC7.56%
ROIC/WACC1.52
Cap/Depr(3y)98.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.25%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.78%
EPS 3Y9.77%
EPS 5YN/A
EPS Q2Q%-51.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.69%
Revenue growth 3Y9.04%
Revenue growth 5YN/A
Sales Q2Q%13.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3Y11.74%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-100.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.03%
OCF growth 3Y-59.44%
OCF growth 5YN/A